Jesus Buonomo, MD
Vascular & Interventional Radiology · Ponce, PRNPI 1306138342
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,528 of the $2,449 with a category attached, or 62.4%. 10 manufacturers reported payments, led by Medtronic at 34.6% of the total. Reporting peaked in 2019 at $1,131 and has fallen 76.0% since, to $272 in 2025.
Across 55 payments — averaging $44.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$847
- Abbott$672
- Boston Scientific$356
- Bard Access Systems, Inc.$166
- Penumbra, Inc.$164
- AbbVie$125
- plus $119 from 4 others
What the payments were for
- Speaking & faculty fees$31513%
- Travel & lodging$60625%
- Food & beverage$1,52862%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $847 |
| Abbott | 24 | $672 |
| Boston Scientific | 8 | $356 |
| Bard Access Systems, Inc. | 1 | $166 |
| Penumbra, Inc. | 1 | $164 |
| AbbVie | 1 | $125 |
| BD | 2 | $58 |
| Cardinal Health P.r. 120 Inc | 2 | $28 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| Cordis US CORP. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IN.PACT Admiral$606
- Proclaim IPG$315
- Indigo System$164
- AVYCAZ$125
- Proclaim Family of SCS IPGs$104
How this compares
$2,449 in reported general payments places this provider in the 75th percentile of 27 vascular & interventional radiology providers in Puerto Rico.
See all vascular & interventional radiology providers in Puerto Rico →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $19,277 |
| ClopidogrelClopidogrel Bisulfate | 55 | $461 |
| Ondansetron OdtOndansetron | 13 | $248 |
| Methylprednisolone | 12 | $106 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Ponce
- Yarelis Vazquez-PerezPonce$975
- Dennis CummingsPonce$286
- Carlos AnayaManati$18K
- Eduardo Gonzalez PonsManati$8K
- Stephanie Torres-AyalaMayaguez$7K
- Roberto Kutcher-DiazSan Juan$6K
- Angel Torres RiveraMayaguez$4K
- Manuel Betancourt TorresLuquillo$3K
- Alejandro Hidalgo RiosSan Juan$2K
- Brandon PaganDorado$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.